C1ql1 expression in oligodendrocyte progenitor cells promotes oligodendrocyte differentiation
Zeynep M. Altunay,Joyshree Biswas,Hiu W. Cheung,Robert S. Pijewski,Lucille E. Papile,Yetunde O. Akinlaja,Andrew Tang,Lyndsay C. Kresic,Alexander D. Schouw,Maksym V. Ugrak,Keaven Caro,Perla A. Peña Palomino,Susanne Ressl,Akiko Nishiyama,Stephen J. Crocker,David C. Martinelli
DOI: https://doi.org/10.1111/febs.17256
2024-09-11
FEBS Journal
Abstract:Myelinating oligodendrocytes arise from oligodendrocyte progenitor cells (OPCs). How OPCs are instructed to differentiate is poorly understood. The C1QL family has been studied for their functions at neuron–neuron synapses, but we show that OPCs express C1ql1. We show that bidirectional modulation of C1ql1 regulates the production of oligodendrocytes and myelin during recovery from demyelination. This suggests that C1QL1 may initiate a previously unrecognized signaling pathway to promote differentiation of oligodendrocytes. Myelinating oligodendrocytes arise from the stepwise differentiation of oligodendrocyte progenitor cells (OPCs). Approximately 5% of all adult brain cells are OPCs. Why would a mature brain need such a large number of OPCs? New myelination is possibly required for higher‐order functions such as cognition and learning. Additionally, this pool of OPCs represents a source of new oligodendrocytes to replace those lost during injury, inflammation, or in diseases such as multiple sclerosis (MS). How OPCs are instructed to differentiate into oligodendrocytes is poorly understood, and for reasons presently unclear, resident pools of OPCs are progressively less utilized in MS. The complement component 1, q subcomponent‐like (C1QL) protein family has been studied for their functions at neuron–neuron synapses, but we show that OPCs express C1ql1. We created OPC‐specific conditional knockout mice and show that C1QL1 deficiency reduces the differentiation of OPCs into oligodendrocytes and reduces myelin production during both development and recovery from cuprizone‐induced demyelination. In vivo over‐expression of C1QL1 causes the opposite phenotype: increased oligodendrocyte density and myelination during recovery from demyelination. We further used primary cultured OPCs to show that C1QL1 levels can bidirectionally regulate the extent of OPC differentiation in vitro. Our results suggest that C1QL1 may initiate a previously unrecognized signaling pathway to promote differentiation of OPCs into oligodendrocytes. This study has relevance for possible novel therapies for demyelinating diseases and may illuminate a previously undescribed mechanism to regulate the function of myelination in cognition and learning.
biochemistry & molecular biology